Biologics May Clear Psoriasis, But Not the Inflammation Behind It, Research Warns
Spain: A new multinational study published in the Journal of Investigative Dermatology has revealed that a significant proportion of psoriasis patients continue to experience underlying systemic inflammation despite achieving near-complete skin clearance through biologic therapy. The research, led by Dr. Alba Lecumberri from the Department of Dermatology, Hospital Universitario Ramón y Cajal in Madrid, Spain, found that over one-third of patients showed signs of residual inflammation, which may carry important implications for their long-term health.
The prospective observational study analyzed data from 209 adults with psoriasis enrolled across three international cohorts in Spain, the United States, and Sweden. All participants were on stable biologic treatments and had achieved a Psoriasis Area Severity Index (PASI) score of 2 or less, reflecting well-controlled skin symptoms.
The study revealed the following findings:
- 36.3% of psoriasis patients had elevated high-sensitivity C-reactive protein (hsCRP ≥ 2 mg/L), indicating residual inflammation (RI) despite skin improvement.
- Higher body mass index (BMI) was significantly associated with the presence of RI.
- Increased visceral adipose tissue was linked to persistent systemic inflammation.
- Metabolic dysfunction–associated steatotic liver disease (MASLD) was common in patients with RI.
- Elevated baseline systemic inflammation was a notable factor in those with residual inflammation.
- Female patients were more likely to experience RI across all study cohorts, indicating possible sex-based differences in inflammatory patterns.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.